会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 13. 发明申请
    • TISSUE TREATMENT SYSTEM AND METHOD FOR TISSUE PERFUSION USING FEEDBACK CONTROL
    • US20080221562A1
    • 2008-09-11
    • US12037882
    • 2008-02-26
    • Robert J. GarabedianAmy C. KellySteve K. Landreville
    • Robert J. GarabedianAmy C. KellySteve K. Landreville
    • A61B18/14A61B18/12
    • A61B18/0206A61B18/12A61B18/1477A61B18/148A61B2018/00005A61B2018/00035A61B2018/00071A61B2018/00577A61B2018/00595A61B2018/00702A61B2018/00875A61B2018/00916A61B2018/00934A61B2018/1425A61B2018/143A61B2018/1432A61B2018/1472A61B2018/1475A61B2218/002
    • A system, ablation probe, and method is provided for treating tissue, e.g., tissue having tumors. The treatment system is configured to automatically deliver infusaid to tissue when needed and comprises an ablation probe having an ablative element and at least one perfusion exit port. The system further comprises an ablation source operably coupled to the ablative element, and a pump assembly operably coupled to the perfusion exit port(s). The pump assembly is configured for pumping infusaid out through the perfusion exit port(s), preferably during the ablation process. The system further comprises a feedback device configured for controlling the amount of infusaid displaced by the pump assembly based on a sensed tissue parameter, e.g., tissue temperature or tissue impedance. For example, the feedback device can comprise a sensor configured for sensing the tissue parameter, and a perfusion controller configured for controlling the pump assembly based on the sensed tissue parameter. As another example, the feedback device can comprise a perfusion valve associated with the distal end of the shaft. In this case, the perfusion valve forms the perfusion exit port, wherein the perfusion valve changes the size of the perfusion exit port based on tissue temperature.An ablation probe is provided for treating tissue, e.g., tissue having a tumor. The ablation comprises an elongated shaft, an ablative element, a perfusion lumen that extends through the probe shaft, and a perfusion control valve associated with the distal end of the shaft. The perfusion control valve has a port, the size of which changes with temperature. In one embodiment, the perfusion control valve comprises a reed valve having at least one reed, e.g., a pair of opposing reeds, or even four reeds. The reeds are configured change shape in order to control the size of the port. For example, each reed can comprise a bimetallic flange or a nitinol flange that bends in the presence of a temperature change.Ablation probes and systems are provided for treating tissue, e.g., tissue having a tumor. The ablation comprises an elongated shaft, an ablative element, a perfusion lumen that extends through the probe shaft, and at least one perfusion exit port in fluid communication with the perfusion lumen. The perfusion lumen can be used to deliver an infusaid to the perfusion exit port(s) for perfusion of the surrounding tissue. The ablation probe further comprises a wicking material, e.g., cotton or fabric, disposed in the perfusion lumen. In this manner, the infusaid that travels through the perfusion lumen can be controlled without regard to the size of the perfusion exit port(s).An ablation probe is provided for treating tissue, e.g., tissue having a tumor. The ablation probe comprises an elongated shaft, an ablative element, a perfusion lumen that extends through the probe shaft, and at least one perfusion exit port in fluid communication with the perfusion lumen. The ablation probe further comprises a pump assembly carried by the proximal end of the shaft. The pump assembly is configured for pumping infusaid through the perfusion lumen and out the perfusion exit port(s). In one embodiment, the pump assembly comprises a reservoir for storing the infusaid, and a perfusion inlet port configured for transferring infusaid from an external source into the reservoir. The pump assembly can be variously configured. For example, the pump assembly may comprise a diaphragm adjacent the reservoir. In this case, the diaphragm has pumping stroke that displaces the infusaid from the reservoir into the perfusion lumen. As another example, the pump assembly comprises a diaphragm adjacent the reservoir, wherein the diaphragm is configured for expanding to pressurize the reservoir in response to the conveyance of infusaid into the reservoir. As still another example, the pump assembly comprises a plunger disposed in the reservoir and a spring configured to urge the plunger within the reservoir in one direction to pressurize the reservoir.
    • 16. 发明申请
    • RADIO FREQUENCY ABLATION COOLING SHIELD
    • 无线电频率冷却屏蔽
    • US20110022044A1
    • 2011-01-27
    • US12849699
    • 2010-08-03
    • Robert J. GarabedianRobert F. Rioux
    • Robert J. GarabedianRobert F. Rioux
    • A61B18/14
    • A61B18/1477A61B18/14A61B90/04A61B2018/00005A61B2018/00017A61B2018/00023A61B2018/00029A61B2018/00577A61B2090/0445A61B2090/0481
    • A medical assembly and method are provided to effectively treat abnormal tissue, such as, a tumor. The target tissue is thermally ablated using a suitable source, such as RF or laser energy. A cooling shield is placed in contact with non-target tissue adjacent the target tissue, and actively cooled to conduct thermal energy away from the non-target tissue. In one method, the cooling shield can be placed between two organs, in which case, one of the two organs can comprise the target tissue, and the other of the two organs can comprise the non-target tissue. In this case, the cooling shield may comprise an actively cooled inflatable balloon, which can be disposed between the two organs when deflated, and then inflated. The inflatable balloon can be actively cooled by pumping a cooling medium through it. In another method, the cooling shield can be embedded within the non-target tissue. In this case, the cooling shield can comprise one or more needles. If a plurality of needles is used, they can be embedded into the non-target tissue in a series, e.g., a rectilinear or curvilinear arrangement. The needle(s) can be actively cooled by pumping a cooling medium through them.
    • 提供医疗组件和方法来有效地治疗诸如肿瘤的异常组织。 使用适当的来源(例如RF或激光能量)将靶组织热消融。 将冷却屏蔽物放置成与目标组织相邻的非靶组织接触,并且主动冷却以将热能从非目标组织传导出去。 在一种方法中,冷却屏蔽可以放置在两个器官之间,在这种情况下,两个器官中的一个可以包括靶组织,并且两个器官中的另一个可以包括非靶组织。 在这种情况下,冷却屏蔽件可以包括主动冷却的可膨胀气囊,当气体放气时可以将气囊放置在两个器官之间,然后膨胀。 可以通过泵送冷却介质来主动冷却可充气球囊。 在另一种方法中,冷却屏蔽可以嵌入在非目标组织内。 在这种情况下,冷却罩可以包括一个或多个针。 如果使用多个针,则它们可以以一系列例如直线或曲线布置被嵌入到非目标组织中。 可以通过将冷却介质泵送通过它们来主动冷却针。
    • 19. 发明授权
    • Intravascular catheter with composite reinforcement
    • 血管内导管与复合增强
    • US06171295B2
    • 2001-01-09
    • US09234203
    • 1999-01-20
    • Robert J. GarabedianJohn GriegoEarl BardsleyDean A. SchaeferCang D. DaoSteven M. Anderson
    • Robert J. GarabedianJohn GriegoEarl BardsleyDean A. SchaeferCang D. DaoSteven M. Anderson
    • A61M2500
    • A61M25/005A61M25/0053
    • An intravascular catheter that exhibits the combined features of superior flexibility, softness, radiopacity and oval/kink resistance. The catheter includes an elongate shaft having a proximal region, a distal region and a lumen extending therethrough. The proximal region of the shaft includes an inner lubricious polymer layer, a reinforcement layer and an outer layer. The reinforcement layer comprises a braid having one or more metallic members and a plurality of polymer members wherein each polymer member comprises a plurality of monofilaments, preferably formed of LCP. The polymer members of the braid provide improved flexibility and softness in addition to high burst pressure. The metallic member(s) of the braid provide improved radiopacity and oval/kink resistance. The catheter may also include a longitudinal member extending along the reinforcement layer.
    • 一种血管内导管,其具有优异的柔韧性,柔软性,不透射线性和椭圆形/扭结阻力的组合特征。 导管包括细长轴,其具有近端区域,远侧区域和延伸穿过其中的内腔。 轴的近侧区域包括内部光滑聚合物层,加强层和外层。 加强层包括具有一个或多个金属构件和多个聚合物构件的编织物,其中每个聚合物构件包括多个单丝,优选由LCP形成。 除了高爆裂压力之外,编织物的聚合物构件提供了改善的柔韧性和柔软性。 编织物的金属构件提供了改善的射线不透性和椭圆形/扭结阻力。 导管还可以包括沿加强层延伸的纵向构件。
    • 20. 发明授权
    • Methods for delivering cortical electrode leads into patient's head
    • 将皮质电极导入患者头部的方法
    • US07937160B2
    • 2011-05-03
    • US11010232
    • 2004-12-10
    • Robert J. GarabedianMichael P. WallaceGary Heit
    • Robert J. GarabedianMichael P. WallaceGary Heit
    • A61N1/05
    • A61N1/0531A61N1/0539A61N1/36082
    • Methods and kits for delivering an electrode lead into the head of a patient are provided. A burr hole is formed within the cranium of the patient, and an electrode lead is threaded through the burr hole. The electrode lead is then placed in a pre-shaped two-dimensional geometry between the cranium and cortical brain tissue of the patient. An access anchor may be mounted into the burr hole to facilitate introduction and removal of the electrode lead and other devices. In some circumstances, it may be desirable to separate the dura mater overlying the cortical brain tissue from the cortical brain tissue to create a pocket in which the electrode lead may be manipulated. In this case, a tissue layer dissection device can be introduced through the burr hole, operated to separate the dura mater from the cranium, and then removed from the burr hole. In one embodiment, the dissection device comprises a balloon that can be inflated to separate the dura mater and cranium, and then deflated prior to removing the dissection device from the burr hole.
    • 提供了用于将电极引线输送到患者头部的方法和套件。 在患者的颅骨内形成有钻孔,电极引线穿过毛刺孔。 然后将电极引线置于患者的颅骨和皮质脑组织之间的预先形状的二维几何形状中。 可以将入口锚固件安装到钻孔中以便于引入和移除电极引线和其它装置。 在某些情况下,可能需要将覆盖皮质脑组织的硬膜与皮层脑组织分离,以产生可以操纵电极引线的口袋。 在这种情况下,可以通过毛刺孔引入组织层解剖装置,操作以将硬脑膜与头颅分开,然后从毛刺孔中取出。 在一个实施例中,解剖装置包括可以充气以分离硬脑膜和颅骨的气囊,然后在从毛刺孔移除解剖装置之前放气。